Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichi Ishikawa

Showing results (1-10 of 507) with videos related to

Pageof 51
Sort By:
The American Journal of Pathology|June 24, 2005
Wnt signaling and orthopedic diseasesYuichi Ishikawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 5, 2021
[Recent advances in molecular targeted therapy for acute myeloid leukemia]Yuichi Ishikawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 17, 2009
[Comprehensive analysis of gene abnormalities in acute myeloid leukemia according to the WHO classification]Yuichi Ishikawa
International Journal of Hematology|October 1, 2024
Recent progress in AML with recurrent genetic abnormalitiesYuichi Ishikawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 4, 2024
[Current status and challenges of AML treatment with FLT3 inhibitors]Yuichi Ishikawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2017
Genetic abnormalities in core binding factor acute myeloid leukemiaYuichi Ishikawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2018
[Molecular pathogenesis and treatment of core binding factor-acute myeloid leukemia]Yuichi Ishikawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 4, 2023
[Molecular targeted therapy for acute myeloid leukemia]Yuichi Ishikawa
Nihon Jinzo Gakkai Shi|September 22, 2015
[CKD management from the viewpoint of the dietitian]Yuichi Ishikawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 9, 2020
[Clinical significance of MRD in AML]Yuichi Ishikawa
Pageof 51

Showing results (1-10 of 507) with videos related to

Sort By:
Pageof 51
The American Journal of Pathology|June 24, 2005
Wnt signaling and orthopedic diseasesYuichi Ishikawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 5, 2021
[Recent advances in molecular targeted therapy for acute myeloid leukemia]Yuichi Ishikawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 17, 2009
[Comprehensive analysis of gene abnormalities in acute myeloid leukemia according to the WHO classification]Yuichi Ishikawa
International Journal of Hematology|October 1, 2024
Recent progress in AML with recurrent genetic abnormalitiesYuichi Ishikawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 4, 2024
[Current status and challenges of AML treatment with FLT3 inhibitors]Yuichi Ishikawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2017
Genetic abnormalities in core binding factor acute myeloid leukemiaYuichi Ishikawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2018
[Molecular pathogenesis and treatment of core binding factor-acute myeloid leukemia]Yuichi Ishikawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 4, 2023
[Molecular targeted therapy for acute myeloid leukemia]Yuichi Ishikawa
Nihon Jinzo Gakkai Shi|September 22, 2015
[CKD management from the viewpoint of the dietitian]Yuichi Ishikawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 9, 2020
[Clinical significance of MRD in AML]Yuichi Ishikawa
Pageof 51